Isoaspartate Formation and Neurodegeneration in Alzheimer's Disease

Author： Shimizu T. Watanabe A. Ogawara M. Mori H. Shirasawa T.

Publisher： Elsevier

ISSN： 0003-9861

Source： Archives of Biochemistry and Biophysics, Vol.381, Iss.2, 2000-09, pp. : 225-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cofilin-mediated neurodegeneration in alzheimer’s disease and other amyloidopathies

By Maloney Michael Bamburg James

Molecular Neurobiology, Vol. 35, Iss. 1, 2007-01 ,pp. : 21-43

Humana Press, Inc

Access to resources Recommend Favorite

Amyloid β-peptide (1-42)-induced Oxidative Stress and Neurotoxicity: Implications for Neurodegeneration in Alzheimer's Disease Brain. A Review

By Allan Butterfield D.

Free Radical Research, Vol. 36, Iss. 12, 2002-01 ,pp. : 1307-1313

Informa Healthcare

Access to resources Recommend Favorite

Formation and participation of nano-amyloids in pathogenesis of Alzheimer's disease and other amyloidogenic diseases

By Maltsev A. Galzitskaya O.

Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, Vol. 4, Iss. 3, 2010-09 ,pp. : 228-236

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Formation of hydrogen peroxide and hydroxyl radicals from A and -synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease 1,2

By Tabner B.J. Turnbull S. El-Agnaf O.M.A. Allsop D.

Free Radical Biology and Medicine, Vol. 32, Iss. 11, 2002-06 ,pp. : 1076-1083

Elsevier

Access to resources Recommend Favorite

Solanezumab for Alzheimer's disease

By Samadi Hossein Sultzer David

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 787-798

Informa Healthcare

Access to resources Recommend Favorite